Longevity · Longevity peptide (research)
Humanin
- Drug class
- Longevity peptide (research)
- Status
- Compounded (503A)
- Reviewed
- 2026-06-01 · Kindr Health Clinical Team
What Humanin is studied for
- Neuroprotection (research)
- Cellular resilience (research)
- Metabolic support (research)
Mechanism of action
Humanin is being studied in the longevity category. Mitochondrial peptide studied for neuroprotection and cellular resilience. Mechanism of action varies by study model; refer to the kindr clinical library for a deeper writeup.
Frequently asked questions
What is Humanin?
Humanin is a longevity peptide. Mitochondrial peptide studied for neuroprotection and cellular resilience.
What is Humanin studied for?
Published research has examined Humanin for neuroprotection, cellular resilience, metabolic support. Human clinical evidence varies by indication.
Is Humanin FDA-approved?
No. Humanin is not FDA-approved for the indications listed. It is available compounded by 503A pharmacies under clinician supervision, or for international research use only on this catalog.
How is Humanin used in research?
Protocols vary by study. Humanin is typically administered subcutaneously in research settings. No validated human therapeutic dose exists outside FDA-approved indications.
What are the known risks?
Long-term human safety data for Humanin is limited. Theoretical risks vary by mechanism. Any human use should be supervised by a licensed clinician.
Build the Humanin protocol stack
Research protocols commonly pair Humanin with the peptides below. Add all three vials to unlock the bundle discount at checkout.
Related peptides in Longevity
Continue across the Kindr entity graph
Related evidence, peptides, and clinical tools on the same topic.
- Is HRT safe?Journal
- When to start HRTJournal
- Menopause HRT serviceMedication
- Complete menopause guideJournal
